MORCE POWER PLUS AND VARIOCARVE MORCELLATOR

K080365 · NOUVAG AG · HET · Jun 29, 2009 · Obstetrics/Gynecology

Device Facts

Record IDK080365
Device NameMORCE POWER PLUS AND VARIOCARVE MORCELLATOR
ApplicantNOUVAG AG
Product CodeHET · Obstetrics/Gynecology
Decision DateJun 29, 2009
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 884.1720
Device ClassClass 2
AttributesTherapeutic

Intended Use

The Morce Power Plus morcellator is intended for use in operative laparoscopy, including laparoscopic general surgical procedures and laparoscopic gynerological procedures to morcellate and remove tissue. The VarioCarve morcellator is intended for morcellating and extracting tissue (e.g. removing myomata or the uterus) during laparoscopic procedures in general surger y and gynecology.

Device Story

The Morce Power Plus / VarioCarve is a drive control unit for a mechanical morcellator. The device consists of a rotating cylindrical tube with a cutting blade at the distal end. It is inserted into the abdominal cavity during operative laparoscopy. Operated by a surgeon, the device mechanically morcellates (cuts into smaller pieces) and extracts tissue, such as myomata or the uterus. The system is used in clinical settings for general surgery and gynecology. The device is designed to facilitate tissue removal through small laparoscopic incisions, potentially reducing the need for larger open surgical incisions.

Clinical Evidence

Bench testing only. No clinical data provided.

Technological Characteristics

Electromechanical drive control unit for a rotating cylindrical tube with a distal cutting blade. Sterilizable by user up to 134°C. Operates as a mechanical morcellator for tissue extraction.

Indications for Use

Indicated for patients undergoing laparoscopic general surgical or gynecological procedures requiring tissue morcellation and extraction, such as myomectomy or hysterectomy.

Regulatory Classification

Identification

A gynecologic laparoscope is a device used to permit direct viewing of the organs within the peritoneum by a telescopic system introduced through the abdominal wall. It is used to perform diagnostic and surgical procedures on the female genital organs. This generic type of device may include: Trocar and cannula, instruments used through an operating channel, scope preheater, light source and cables, and component parts.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ NOUVAG AG Morcellator K080365 510(k) Notification June 25, 2009 #### SECTION 10 ### 510(k) Summary JUN 29 2009 Submitter: NOUVAG AG St. Gallerstrasse 23-25 CH-9403 Goldach Switzerland Contact Person: Erich Forster (INTRATest GmbH) Consultant Phone +41 56 201 95 00 Fax +41 56 201 95 05 Date Summary Prepared: June 25, 2009 Device Name: Proprietary Name Morce Power Plus Morcellator (Distributed by Richard Wolf) VarioCarve Morcellator (Distributed by Olympus) Common Name Morcellator Classification Name Gynecologic laparoscope and accessories (per 21 CFR section 884.1720) Identification of the predicate device or legally marketed device or devices to which substantial equivalence is being claimed: ETHICON, Inc. GYNECARE X-TRACT Tissue Morcellator K993801, Cleared on 02/07/2000 WISAP Gesellschaft für wissenschaftl. App.bau S*E*E*M SET K960640, cleared on 02/14/1997 WISAP Gesellschaft für wissenschaftl. App.bau POWER-DRIVE,WISAP Model 7688PD/7688PD1 K982515, cleared on 01/19/1999 {1}------------------------------------------------ K080365 510(k) Notification June 25, 2009 ### Device Description: The Morce Power Plus / VarioCarve is the drive control unit for the morcellator. With a cutting blade on the distal end, a rotating cylindrical tube is inserted in the abdominal cavity. Sterility: Motor, motorcable, and morcellator: Sterility by user up to 134℃. ## Intended use of the Devices: Morce Power Plus Morcellator (Distributed by Richard Wolf) The Morce Power Plus morcellator is intended for use in operative laparoscopy, including laparoscopic general surgical procedures and laparoscopic gynerological procedures to morcellate and remove tissue. ### VarioCarve Morcellator (Distributed by Olympus) The VarioCarve morcellator is intended for morcellating and extracting tissue (e.g. removing myomata or the uterus) during laparoscopic procedures in general surger y and gynecology. Statement of how the technological characteristics of the device compare to those of the predicate or legally marketed device: The Morcellator is substantially equivalent to other legally marketed devices in the United States. The Morcellator functions in a manner similar and are intended for the same use as the Devices designed by Ethicon, Inc. and WISAP Gesellschaft für wissenschaftl.18 probau ## Brief summary of nonclinical tests and results: The Morcellator has been designed and tested to applicable safety standards. The Morcellator does not raise any new issues of safety, effectiveness, or performance of the product. {2}------------------------------------------------ Image /page/2/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle or bird-like figure with three curved lines representing its body and wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the bird-like figure. ### DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration . 9200 Corporate Boulevard Rockville MD 20850 # JUN 2 9 2009 Nouvag AG c/o Mr. Erich Forster INTRATest Systems GmbH Reusswehrstrasse 1 Gebenstorf SWITZERLAND CH-5412 K080365 Re: > Trade/Device Name: Morce Power Plus Morcellator (Distributed by Richard Wolf) VarioCarve Morcellator (Distributed by Olympus) Regulation Number: 21 CFR §884.1720 Regulation Name: Gynecologic laparoscope and accessories Regulatory Class: II Product Code: HET Dated: June 8, 2009 Received: June 16, 2009 Dear Mr. Forster: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Isting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA). it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations. Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical {3}------------------------------------------------ device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/cdrh/mdr/ for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda:gov/cdrh/industry/support/index.html. Sincerely yours, Jayne M. Morris Janine M. Morris Acting Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ ## Indications for Use 510(k) Number (if known): K080365 Device Name:__ Morce Power Plus Morcellator (Distributed by Richard Wolf) Indications For Use: The Morce Power Plus morcellator is intended for use in operative laparoscopy, including laparoscopic general surgical procedures and laparoscopic gyrocological procedures to morcellate and remove tissue. Prescription Use x (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) (Division Sign-Off) Division of Reproductive, Abdominal, and Radiological Devi 510(k) Number Page 1 of 1 {5}------------------------------------------------ ## Indications for Use 510(k) Number (if known):__K080365 Device Name:__VarioCarve Morcellator (Distributed by Olympus) Indications For Use: The VarioCarve morcellator is intended for morcellating and extracting tissue (e.g. removing myomata or the uterus) during laparoscopic procedures in general surgery and gynecology. Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Hullem Divisid Division of Reproductive, Abdominal, and Radiological Device 510(k) Number Page 1 of 1
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%